{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:08:50Z","timestamp":1790446130353,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jbiotec.2020.01.016","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T11:06:32Z","timestamp":1580555192000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection"],"prefix":"10.1016","volume":"310","author":[{"given":"Zohre","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fasihi-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2020.01.016_bib0005","first-page":"11","article-title":"A Recombinant Chimera Protein as a Novel Brucella Subunit Vaccine: Protective Efficacy and Induced Immune Response in BALB\/c Mice","volume":"21","author":"Abdollahi","year":"2017","journal-title":"Evaluation."},{"issue":"8","key":"10.1016\/j.jbiotec.2020.01.016_bib0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apm.12400","article-title":"Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections","volume":"123","author":"Abkar","year":"2015","journal-title":"Apmis."},{"issue":"4","key":"10.1016\/j.jbiotec.2020.01.016_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11259-015-9645-2","article-title":"Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization","volume":"39","author":"Abkar","year":"2015","journal-title":"Vet. Res. Commun."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.20506\/rst.32.1.2187","article-title":"Epidemiology of brucellosis in domestic animals caused by Brucella melitensis, Brucella suis and Brucella abortus","volume":"32","author":"Aparicio","year":"2013","journal-title":"Rev sci tech Off int Epiz."},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/743509","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calder\u00f3n","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"1\u20134","key":"10.1016\/j.jbiotec.2020.01.016_bib0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0378-1135(02)00222-5","article-title":"Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection","volume":"90","author":"Baldwin","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0035","series-title":"Novel Mucosal Adjuvants and Delivery Systems","author":"Billy","year":"2012"},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-animal-021815-111326","article-title":"Brucella spp. virulence factors and immunity","volume":"4","author":"Byndloss","year":"2016","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"10","key":"10.1016\/j.jbiotec.2020.01.016_bib0045","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.jbiotec.2020.01.016_bib0050","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerging Infect. Dis."},{"issue":"6","key":"10.1016\/j.jbiotec.2020.01.016_bib0060","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis: review of Brucella\u2013Host Interactions","volume":"185","author":"de Figueiredo","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0065","first-page":"97","article-title":"Chitosan-based intranasal vaccine against Escherichia coli O157: H7","volume":"20","author":"Doavi","year":"2016","journal-title":"Iran. Biomed. J."},{"issue":"1\u20134","key":"10.1016\/j.jbiotec.2020.01.016_bib0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0378-1135(02)00223-7","article-title":"The innate immune response against Brucella in humans","volume":"90","author":"Dornand","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet. Res."},{"issue":"31","key":"10.1016\/j.jbiotec.2020.01.016_bib0080","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.vaccine.2015.05.057","article-title":"Immune response triggered by Brucella abortus following infection or vaccination","volume":"33","author":"Dorneles","year":"2015","journal-title":"Vaccine."},{"issue":"7","key":"10.1016\/j.jbiotec.2020.01.016_bib0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3855\/jidc.6625","article-title":"Host response to Brucella infection: review and future perspective","volume":"9","author":"Elfaki","year":"2015","journal-title":"J. Infect. Dev."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/21691401.2017.1290646","article-title":"Vibrio cholerae lipopolysaccharide loaded chitosan nanoparticle could save life by induction of specific immunoglobulin isotype","volume":"46","author":"Fasihi-Ramandi","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"2\u20133","key":"10.1016\/j.jbiotec.2020.01.016_bib0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.colsurfb.2005.06.001","article-title":"Modulation of surface charge, particle size and morphological properties of chitosan\u2013TPP nanoparticles intended for gene delivery","volume":"44","author":"Gan","year":"2005","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"49","key":"10.1016\/j.jbiotec.2020.01.016_bib0100","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.vaccine.2014.09.013","article-title":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection","volume":"32","author":"Ghasemi","year":"2014","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice","volume":"62","author":"Ghasemi","year":"2014","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.jbiotec.2020.01.016_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e01079","article-title":"Development of new generation of vaccines for Brucella abortus","volume":"4","author":"Gheibi","year":"2018","journal-title":"Heliyon."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molimm.2015.01.009","article-title":"Vaccination with recombinant L7\/L12-truncated Omp31 protein induces protection against Brucella infection in BALB\/c mice","volume":"65","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.jbiotec.2020.01.016_bib0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijmm.2017.03.004","article-title":"Protein\/Protein, DNA\/DNA and DNA\/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB\/c Mice","volume":"307","author":"Golshani","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0125","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.ijbiomac.2017.01.147","article-title":"Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method","volume":"104","author":"Gomathi","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.jbiotec.2020.01.016_bib0130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1523-1755.1999.00369.x","article-title":"Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis","volume":"55","author":"Holdsworth","year":"1999","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.jbiotec.2020.01.016_bib0135","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.biomaterials.2007.12.025","article-title":"The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization","volume":"29","author":"Jiang","year":"2008","journal-title":"Biomaterials."},{"issue":"9\u201310","key":"10.1016\/j.jbiotec.2020.01.016_bib0140","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1166\/jnn.2006.434","article-title":"Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan\/DNA nanoparticles","volume":"6","author":"Kim","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jddst.2017.11.022","article-title":"Novel approach to improve vaccine immunogenicity: Mannosylated chitosan nanoparticles loaded with recombinant hepatitis B antigen as a targeted vaccine delivery system","volume":"44","author":"Mehrabi","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0160","first-page":"1","article-title":"Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant","author":"Mehrabi","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.08.054","article-title":"Immunomodulatory properties of chitosan polymers","volume":"184","author":"Moran","year":"2018","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jbiotec.2020.01.016_bib0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biologicals.2014.01.002","article-title":"Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1\u2013OmpA in guinea pigs","volume":"42","author":"Nanda","year":"2014","journal-title":"Biologicals."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1637\/9986-111011-Reg.1","article-title":"Efficacy of soluble recombinant FliC protein from Salmonella enterica serovar Enteritidis as a potential vaccine candidate against homologous challenge in chickens","volume":"56","author":"Okamura","year":"2012","journal-title":"Avian Dis."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2004.12.009","article-title":"Interferon-\u03b3 associated cytokines and chemokines produced by spleen cells from Brucella-immune mice","volume":"30","author":"Paranavitana","year":"2005","journal-title":"Cytokine."},{"issue":"10","key":"10.1016\/j.jbiotec.2020.01.016_bib0190","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1128\/IAI.69.10.6541-6544.2001","article-title":"Mouse Cytokine Profiles Associated withBrucella abortus RB51 Vaccination or B. abortus2308 Infection","volume":"69","author":"Pasquali","year":"2001","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0195","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.jbiotec.2020.01.016_bib0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"issue":"17\u201319","key":"10.1016\/j.jbiotec.2020.01.016_bib0205","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","article-title":"Reverse vaccinology, a genome-based approach to vaccine development","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine."},{"issue":"5","key":"10.1016\/j.jbiotec.2020.01.016_bib0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"issue":"4","key":"10.1016\/j.jbiotec.2020.01.016_bib0215","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity."},{"issue":"43","key":"10.1016\/j.jbiotec.2020.01.016_bib0220","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.vaccine.2014.07.106","article-title":"Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis","volume":"32","author":"Singh","year":"2014","journal-title":"Vaccine."},{"issue":"6","key":"10.1016\/j.jbiotec.2020.01.016_bib0225","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/cmi.12088","article-title":"Innate immune recognition of flagellin limits systemic persistence of B rucella","volume":"15","author":"Terwagne","year":"2013","journal-title":"Cell. Microbiol."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines."},{"issue":"10","key":"10.1016\/j.jbiotec.2020.01.016_bib0235","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.jbiotec.2020.01.016_bib0240","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/omi.2015.0105","article-title":"Novel vaccine candidates against brucella melitensis identified through reverse vaccinology approach","volume":"19","author":"Vishnu","year":"2015","journal-title":"Omics A J. Integr. Biol."},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0245","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1302561","article-title":"Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis","author":"Vitry","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbiotec.2020.01.016_bib0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fcimb.2017.00445","article-title":"Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge","volume":"7","author":"Wu","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.jbiotec.2020.01.016_bib0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/molecules23020229","article-title":"Chemical modification of chitosan for efficient vaccine delivery","volume":"23","author":"Xing","year":"2018","journal-title":"Molecules."},{"issue":"1","key":"10.1016\/j.jbiotec.2020.01.016_bib0260","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(02)00548-3","article-title":"Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles","volume":"250","author":"Xu","year":"2003","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165620300183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165620300183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:51:45Z","timestamp":1759150305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165620300183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":52,"alternative-id":["S0168165620300183"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2020.01.016","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2020.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}